Ginkgo Bioworks (NYSE: DNA) today confirmed that it has collected, identified, and sequenced three samples containing the novel BA.3 sublineage of the Omicron variant.
Olive Labs announced their partnership with Concentric by Ginkgo to provide a scalable, accessible, and simple testing modality for COVID-19 - pooled testing - to serve schools operating hybrid or in-person learning.